Danaher Corp (DHR)

Add to Watchlists
Create an Alert
146.47 +0.72  +0.49% NYSE Sep 20, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/18/2019 08:00 EDT Misc Danaher Corp Third Quarter Earnings Conference Call in 2019
10/18/2019 Earnings Danaher Corp Third Quarter Earnings in 2019 Release
09/26/2019 Dividends Amount: 0.17, Declared Date: Sep 10 2019, Pay Date: Oct 25 2019
07/18/2019 08:00 EDT Misc Danaher Corp Second Quarter Earnings Conference Call in 2019
07/18/2019 Earnings Danaher Corp Second Quarter Earnings in 2019 Release
06/27/2019 Dividends Amount: 0.17, Declared Date: May 07 2019, Pay Date: Jul 26 2019
05/07/2019 Misc Danaher Corp Annual General Meeting in 2018
04/18/2019 08:00 EDT Misc Danaher Corp First Quarter Earnings Conference Call in 2019
04/18/2019 Earnings Danaher Corp First Quarter Earnings in 2019 Release
03/28/2019 Dividends Amount: 0.17, Declared Date: Mar 08 2019, Pay Date: Apr 26 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.danaher.com
  • Investor Relations URL: http://investors.danaher.com/
  • HQ State/Province: District of Columbia
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Oct. 18, 2019
  • Last Earnings Release: Jul. 18, 2019
  • Next Ex-Dividend Date: Sep. 26, 2019
  • Last Ex-Dividend Date: Jun. 27, 2019
  • Description: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.

Top Fund Holders

Symbol Name Weighting
PHO Invesco Water Resources ETF 7.90%
IHI iShares US Medical Devices ETF 7.21%
PRILX Parnassus Core Equity Institutional 3.48%
PACLX T. Rowe Price Capital Appreciation Adv 3.15%
VDIGX Vanguard Dividend Growth Inv 2.86%
XLV Health Care Select Sector SPDR® ETF 2.67%
VHT Vanguard Health Care ETF 2.18%
MTUM iShares Edge MSCI USA Momentum Fctr ETF 1.97%
EBVLX MFS Value 529B 1.77%
VGHCX Vanguard Health Care Inv 1.33%
RRBGX T. Rowe Price Blue Chip Growth R 1.26%
IWD iShares Russell 1000 Value ETF 0.64%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("DHR","name")
  • Description: =YCI("DHR","description")
  • Sector: =YCI("DHR","sector")
  • Industry: =YCI("DHR","industry")
  • Est. Current Fiscal Year End: =YCI("DHR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.